Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03904017 · ClinicalTrials.gov registry record · NA
The Role of Hyperoxia in Acute Ischemic Stroke
A NA study, sponsored by University of Colorado, Denver.
- Terminated
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT03904017 is a NA study that was terminated before completion, run by University of Colorado, Denver. The registered enrollment target is 13 participants.
The verdict
NCT03904017, a NA study, was terminated before completion, sponsored by University of Colorado, Denver.
- TERMINATED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
This study is being conducted to evaluate the potential therapeutic role of hyperoxia when applied in the immediate ischemic period following a stroke in the controlled Emergency Department setting. The study will evaluate the effects of hyperoxia in stroke patients on the production of markers of free radical damage and inflammatory markers associated with hyperoxic lung injury.
Interventions
- OTHER placebo
- OTHER Oxygen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2019-06-28 |
| Est. Completion | 2023-02-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03904017
The ClinicalTrials.gov registry entry for NCT03904017 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT03904017 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03904017 about?
NCT03904017 is a clinical study titled "The Role of Hyperoxia in Acute Ischemic Stroke". This study is being conducted to evaluate the potential therapeutic role of hyperoxia when applied in the immediate ischemic period following a stroke in the controlled Emergency Department setting. The study will evaluate the effects of hyperoxia in stroke patients on the production of markers of f...
What is the current status of trial NCT03904017?
This trial is currently terminated. It is a NA study. The enrollment target is 13 participants. The study started on 2019-06-28. Estimated completion is 2023-02-01.
What interventions are being tested in trial NCT03904017?
The interventions under investigation include: placebo (OTHER), Oxygen (OTHER).
Who is sponsoring clinical trial NCT03904017?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.